Arbor Biotechnologies cuts early-stage discovery work, lays off staff
Arbor Biotechnologies is trimming its early-stage discovery work, leading to layoffs in the group.
The move was confirmed by an Arbor spokesperson, with CEO Devyn …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.